Alpha Tau reports 100% disease control in pancreatic cancer trials
Go back to Alpha Tau reports 100% disease control in pancreatic cancer trials| (NASDAQ: DRTS) | Delayed: 14.11 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $14.11 | 52 Week High | $ | |||
| Open | $14.11 | 52 Week Low | $ | |||
| Day High | $14.11 | P/E | N/A | |||
| Day Low | $14.11 | EPS | $ | |||
| Volume | 10 | |||||
| (NASDAQ: DRTSW) | Delayed: 3.60 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.60 | 52 Week High | $ | |||
| Open | $3.60 | 52 Week Low | $ | |||
| Day High | $3.60 | P/E | N/A | |||
| Day Low | $3.60 | EPS | $ | |||
| Volume | 1 | |||||

